XML 42 R36.htm IDEA: XBRL DOCUMENT

Non-controlling Interest (Tables)

3 Months Ended

Mar. 31, 2025

Noncontrolling Interest [Abstract]

Schedule Of Approximate Interests In Certain Consolidated Subsidiaries

Non-controlling interest recorded in our condensed consolidated financial statements as of March 31, 2025 and December 31, 2024, relates to the following approximate interests in certain consolidated subsidiaries, which we do not own.


		March 31, 2025				December 31, 2024
MiNK Therapeutics, Inc.			45	%			45	%
SaponiQx, Inc.			30	%			30	%

Schedule Of Changes In Non-controlling Interest

Changes in non-controlling interest for the periods ended March 31, 2025 and December 31, 2024, were as follows (in thousands):


		March 31, 2025				December 31, 2024
Beginning balance		$	19,956			$	11,949

Net loss attributable to non-controlling interest			(1,104	)			(5,059	)

Other items:
Sale of subsidiary shares in private placement			—				10,234
Issuance of subsidiary shares for employee stock purchase plan and exercise of options			1				20
Subsidiary share-based compensation			597				2,812
Total other items			598				13,066

Ending balance		$	19,450			$	19,956